Examining Clinical Outcomes and Management Strategies in Wheat Pill Poisoning
DOI:
https://doi.org/10.51846/jucmd.v3i2.3038Keywords:
Aluminium phosphide, Wheat pill poisoning, Management strategies, Ionotropic supportAbstract
Objective: To retrospectively analyze the clinical presentation and management strategies of patients whodied from wheat pill poisoning.
Methodology: A retrospective study was conducted in the Department of Medicine in Divisional Headquarters teaching Hospital, Azad Kahmir, in which 12 deaths caused by wheat pill poisoning were analyzed. All patients who died from wheat pill poisoning from
October 2019 to October 2022 were included in study. The presenting symptoms, clinical findings, initial resuscitation, management and mode of death was recorded for all cases.
Results: A total of 12 cases were included, with a mean age of 27 ± 12.2 years. There were 2 males (16.6%) and 10 females (83.3%). The main presenting symptoms were vomiting (11 cases, 92%) and irritability (7 cases, 58%). Pre-existing psychiatric illness was present in
4 of the 12 cases (33%). The majority of the patients (92%) died within 48 hours of pill ingestion. In most cases, the mode of death was cardiac arrhythmias, with other modes including recalcitrant shock, metabolic acidosis, and myocardial infarction. Management
strategies included initial assessment of airway, breathing, and circulation, system management to stabilize symptoms and maintain cardiovascular function, and advanced treatments such as magnesium sulfate administration and considering hemodialysis in severe
cases.
Conclusion: The study found that among the 12 cases of wheat pill poisoning, the majority were young females, with high mortality rates primarily due to cardiac arrhythmias. Prompt hospital arrival and medical management are crucial, as most deaths occurred
within 48 hours of ingestion.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Qurat-ul -ain Ayuba, Sardar Muhammad

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository, in a journal or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process.








